PKCα and MAP kinase are independently and obligatorily required for P2U-purinergic receptor-coupled regulation of arachidonic acid release in MDCK-D1 cells

Mingzhao Xing, Paul A. Insel

Research output: Contribution to journalArticle

Abstract

Although involvement of protein kinase C (PKC) and MAP kinase (MAPK) has been implicated in the regulation of the 85-kDa cytosolic phospholipase A2 (cPLA2) and arachidonic acid (AA) release in many cells, whether the two kinases function sequentially or independently remains undefined. We found that blockade of MAPK stimulation by the MAPK kinase inhibitor PD098059 inhibited AA release promoted by P2u, agonists ATP and UTP in MDCK-D1 cells. Down-regulation of PKC inhibited both AA release and MAPK activation. The data thus suggest sequential activation of PKC then MAPK in the regulation of AA release induced by P2U-purinergic receptors. On the other hand, the selective PKCα inhibitor GF109203 X, at < 3 μM, inhibited P2U-purinergic-mediated AA release, but not MAPK activation. Similar differential effects of this inhibitor (at <1 μM) were observed for PMA-mediated responses. Furthermore, partial blockade of expression of PKCα with antisense transfection inhibited PMA-promoted AA release without affecting MAPK stimulation. Thus, PKCα is required for AA release but not for MAPK activation. Together with our previous results that P2U receptors promote AA release through cPLA2 in MDCK-D1 cells, the present study suggests that in these cells PKCα and MAPK, acting independently, are both obligatorily required for the regulation of cPLA2 activation and AA release by P2U-purinergic receptors.

Original languageEnglish (US)
Pages (from-to)A985
JournalFASEB Journal
Volume10
Issue number6
StatePublished - Dec 1 1996

    Fingerprint

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Genetics

Cite this